NCT06310135

Brief Summary

The aim of this study is to determine the relative effectiveness of monocular and binocular light exposures, with and without selective blue-blocking filtering, on nocturnal melatonin suppression, subjective sleepiness, and visual performance of night shift workers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

March 6, 2024

Last Update Submit

July 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Melatonin Levels AUC

    Melatonin levels to assess Melatonin Suppression. Saliva samples will be collected every 30 minutes for melatonin levels.

    Each night for 6 study nights

Secondary Outcomes (2)

  • Karolinska Sleepiness scale to measure Subjective Sleepiness

    Each night for 6 study nights

  • Numerical Verification Task (NVT)

    Each night for 6 study nights

Study Arms (5)

Unfiltered Monocular

EXPERIMENTAL

Unfiltered monocular with the non-dominant eye occluded.

Device: Unfiltered Eyewear

Filtered Binocular

EXPERIMENTAL

Filtered binocular with both eyes filtered.

Device: Filtered Eyewear

Filtered Monocular

EXPERIMENTAL

Filtered monocular with non-dominant eye filtered, the other non-filtered.

Device: Filtered Eyewear

Unfiltered Binocular

EXPERIMENTAL

Unfiltered binocular - neither eye will be filtered.

Device: Unfiltered Eyewear

Dim Light Control

PLACEBO COMPARATOR

Dim light with no filters.

Other: No Filters

Interventions

Filtered binocular viewing condition will be produced by eyeglasses frames with orange-tinted blue-blocking filter, eliminating all optical radiation for wavelengths shorter than 540 nm. For the filtered monocular condition, only the lens on the eyeglasses frame on the non-dominant eye will be tinted with the blue-blocking filter.

Filtered BinocularFiltered Monocular

For the unfiltered binocular, the subjects will wear transparent eyeglasses frames with no optical power. Unfiltered monocular vision will be produced by an opaque eyepatch occluding the non-dominant eye.

Unfiltered BinocularUnfiltered Monocular

Dim lights with no filters.

Dim Light Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy

You may not qualify if:

  • Bipolar disorder
  • Seasonal depression
  • Diabetes
  • High blood pressure
  • History of cancer
  • Obstructing cataracts
  • Macular degeneration
  • Diabetic retinopathy
  • Glaucoma
  • Use of melatonin supplements
  • Use of beta blockers
  • Use of sleep medications
  • Use of antidepressant medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Light and Health Research Center

Menands, New York, 12204, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Mariana Figueiro

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 15, 2024

Study Start

May 1, 2024

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

August 5, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

overall results will be shared, not individual results

Locations